Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non‐D and non‐K‐alloimmunized pregnancies-Reference-Cited by-同舟云学术

Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non‐D and non‐K‐alloimmunized pregnancies

Published:2019-12-23 Issue:2 Volume:60 Page:391-399
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Koelewijn Johanna Maria¹^ORCID,Slootweg Yolentha Maria²³,Folman Claudia⁴,Kamp Inge Louise²,Oepkes Dick²,Haas Masja³⁵⁴

Affiliation:

1. Department of Experimental Immunohematology Sanquin Research and Landsteiner Laboratory Amsterdam The Netherlands

2. Department of Obstetrics Leiden University Medical Center Leiden The Netherlands

3. Center of Clinical Transfusion Research Sanquin Research and Leiden University Medical Center Leiden The Netherlands

4. Department of Diagnostic Services Sanquin Amsterdam The Netherlands

5. Department of Immunohematology and Blood Transfusion Leiden University Medical Center Leiden The Netherlands

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15631

Reference19 articles.

1. Antenatal care for uncomplicated pregnancies;National Institute for Health and Care Excellence (NICE);Clinical Guideline,2008

2. ACOG Practice Bulletin No. 192: management of alloimmunization during pregnancy;American College of Obstetricians and Gynecologists (ACOG);Obstet Gynecol,2018

3. Haemolytic disease of the fetus and newborn

4. Doppler Ultrasonography versus Amniocentesis to Predict Fetal Anemia

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of red cell alloantibodies other than anti-D during pregnancy and their effect on the newborn: A case series;Indian Journal of Obstetrics and Gynecology Research;2023-11-15

2. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes;BMC Pregnancy and Childbirth;2023-10-18

3. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010;AJOG Global Reports;2023-05

4. Immunohematological testing and transfusion management of the prenatal patient;Advances in Clinical Chemistry;2023

5. Management of the Prevention of the Rhesus Alloimmunization: Case of the Mother-Child Hospital Dominique Ouattara of Bingerville/Ivory Coast/West Africa;Open Journal of Obstetrics and Gynecology;2023